Last reviewed · How we verify

NCT04294563

Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty

Terminated NA Last updated 21 April 2023
What this trial tests

NA trial testing Peanut Protein Powder in Surgery in 1 participant. Terminated before completion.

Timeline
1 August 2021
Primary endpoint
1 April 2022
1 April 2022

Quick facts

Lead sponsorAuburn University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment1
Start date1 August 2021
Primary completion1 April 2022
Estimated completion1 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Auburn University

Who can join

Adults 60 to 75, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial will study the effects of peanut protein supplementation on changes in muscle size and quality in patients undergoing total knee arthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Peanut Protein Powder

Trials testing the same drug.

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Auburn University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04294563.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing